We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PPLI icon
251
People Inc
PPLI
$3.04B
$1.29M 0.04%
+33,523
New +$1.39M
2024 Q2
0 quarters
AAT icon
252
American Assets Trust
AAT
$1.32B
$1.28M 0.04%
57,328
+9,228
+19% +$198K
2024 Q1
1 quarter
AGEN icon
253
Agenus
AGEN
$346M
$1.26M 0.04%
+75,189
New +$908K
2024 Q2
0 quarters
KRC icon
254
Kilroy Realty
KRC
$3.98B
$1.26M 0.04%
40,382
-8,343
-17% -$277K
2023 Q4
2 quarters
IFRX icon
255
InflaRx
IFRX
$236M
$1.26M 0.04%
721,768
+339,359
+89% +$498K
2023 Q2
4 quarters
KLAC icon
256
KLA
KLAC
$255B
$1.24M 0.03%
+15,000
New +$1.11M
2024 Q2
0 quarters
IVT icon
257
InvenTrust Properties
IVT
$2.32B
$1.23M 0.03%
49,669
-9,706
-16% -$240K
2024 Q1
1 quarter
AXSM icon
258
Axsome Therapeutics
AXSM
$8.82B
$1.22M 0.03%
15,118
+6,200
+70% +$459K
2022 Q1
9 quarters
SWTX icon
259
DELISTED
SpringWorks Therapeutics
SWTX
$1.21M 0.03%
32,214
-15,036
-32% -$633K
2022 Q1
9 quarters
NVNO icon
260
enVVeno Medical
NVNO
$6.08M
$1.21M 0.03%
6,594
+128
+2% +$22.3K
2022 Q1
9 quarters
LION icon
261
Lionsgate Studios
LION
$3.31B
$1.21M 0.03%
+150,000
New +$1.27M
2024 Q2
0 quarters
ITCI icon
262
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.16M 0.03%
+17,000
New +$1.18M
2024 Q2
0 quarters
DYN icon
263
Dyne Therapeutics
DYN
$3.11B
$1.16M 0.03%
32,944
-181
-0.5% -$5.26K
2022 Q1
9 quarters
FNA icon
264
DELISTED
Paragon 28, Inc.
FNA
$1.14M 0.03%
166,743
+47,098
+39% +$398K
2023 Q1
5 quarters
EVLV icon
265
Evolv Technologies
EVLV
$821M
$1.13M 0.03%
444,123
-362,500
-45% -$1.2M
2021 Q3
11 quarters
GLOB icon
266
Globant
GLOB
$1.57B
$1.13M 0.03%
+6,317
New +$1.11M
2024 Q2
0 quarters
CRNX icon
267
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.13M 0.03%
25,121
+19,100
+317% +$882K
2022 Q1
9 quarters
STNE icon
268
StoneCo
STNE
$2.87B
$1.12M 0.03%
+93,614
New +$1.38M
2024 Q2
0 quarters
ANNX icon
269
Annexon
ANNX
$762M
$1.12M 0.03%
228,277
-20,000
-8% -$103K
2022 Q1
9 quarters
ALCY icon
270
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.11M 0.03%
103,486
– –
2024 Q1
1 quarter
MRSN icon
271
DELISTED
Mersana Therapeutics
MRSN
$1.09M 0.03%
21,772
+4,400
+25% +$318K
2023 Q3
3 quarters
ALC icon
272
Alcon
ALC
$31B
$1.09M 0.03%
12,254
+6,200
+102% +$529K
2024 Q1
1 quarter
HYAC icon
273
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.09M 0.03%
103,486
– –
2023 Q3
3 quarters
ATEC icon
274
Alphatec Holdings
ATEC
$1.65B
$1.08M 0.03%
103,771
-19,050
-16% -$222K
2023 Q4
2 quarters
CGEM icon
275
Cullinan Oncology
CGEM
$999M
$1.08M 0.03%
61,975
+2,623
+4% +$55.9K
2023 Q2
4 quarters
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.